Latest Insider Transactions at Ardelyx, Inc. (ARDX)
This section provides a real-time view of insider transactions for Ardelyx, Inc. (ARDX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ARDELYX, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ARDELYX, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2023
|
Michael Raab President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+21.56%
|
-
|
|
Jan 05
2023
|
Laura A Williams Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
78,000
+19.49%
|
-
|
|
Jan 05
2023
|
Susan Rodriguez Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
78,000
+17.78%
|
-
|
|
Jan 05
2023
|
Justin A Renz Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
78,000
+18.66%
|
-
|
|
Jan 05
2023
|
Elizabeth A Grammer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
78,000
+18.98%
|
-
|
|
Jan 05
2023
|
Robert Blanks Officer |
BUY
Grant, award, or other acquisition
|
Direct |
78,000
+22.26%
|
-
|
|
Jan 05
2023
|
Robert Ora Felsch Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,000
+18.13%
|
-
|
|
Jan 05
2023
|
David P. Rosenbaum Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
25,325
+18.15%
|
-
|
|
Jan 05
2023
|
David P. Rosenbaum Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
78,000
+17.07%
|
-
|
|
Nov 22
2022
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
1,464
-0.25%
|
$1,464
$1.94 P/Share
|
|
Nov 22
2022
|
Laura A Williams Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,241
-0.17%
|
$1,241
$1.94 P/Share
|
|
Nov 22
2022
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,504
-0.29%
|
$1,504
$1.95 P/Share
|
|
Nov 22
2022
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
6,219
-0.31%
|
$6,219
$1.94 P/Share
|
|
Nov 22
2022
|
Susan Rodriguez Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,456
-0.4%
|
$3,456
$1.94 P/Share
|
|
Nov 22
2022
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
1,242
-0.16%
|
$1,242
$1.94 P/Share
|
|
Nov 22
2022
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
484
-0.18%
|
$484
$1.95 P/Share
|
|
Nov 22
2022
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,464
-0.16%
|
$1,464
$1.95 P/Share
|
|
Nov 17
2022
|
David M Mott Director |
BUY
Open market or private purchase
|
Direct |
567,000
+32.7%
|
$567,000
$1.76 P/Share
|
|
Oct 05
2022
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
100,000
-33.8%
|
$100,000
$1.5 P/Share
|
|
Sep 01
2022
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
3,000
-3.25%
|
$0
$0.92 P/Share
|
|
Aug 31
2022
|
Robert Ora Felsch Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+3.18%
|
$0
$0.62 P/Share
|
|
Aug 31
2022
|
David P. Rosenbaum Chief Development Officer |
BUY
Open market or private purchase
|
Indirect |
3,000
+3.15%
|
$0
$0.62 P/Share
|
|
Aug 31
2022
|
Justin A Renz Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+1.13%
|
$0
$0.62 P/Share
|
|
Aug 31
2022
|
Laura A Williams Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+1.21%
|
$0
$0.62 P/Share
|
|
Aug 31
2022
|
Michael Raab President & CEO |
BUY
Open market or private purchase
|
Direct |
3,000
+0.45%
|
$0
$0.62 P/Share
|
|
Aug 31
2022
|
Elizabeth A Grammer Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+1.16%
|
$0
$0.62 P/Share
|
|
Aug 26
2022
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
21,842
-6.88%
|
$21,842
$1.04 P/Share
|
|
Aug 22
2022
|
Susan Rodriguez Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,420
-0.59%
|
$0
$0.98 P/Share
|
|
Aug 22
2022
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
497
-0.28%
|
$0
$0.98 P/Share
|
|
Aug 22
2022
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,458
-0.24%
|
$0
$0.98 P/Share
|
|
Aug 22
2022
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
1,458
-0.23%
|
$0
$0.98 P/Share
|
|
Aug 22
2022
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
6,146
-0.31%
|
$0
$0.98 P/Share
|
|
Aug 22
2022
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
1,236
-0.16%
|
$0
$0.98 P/Share
|
|
Aug 22
2022
|
Laura A Williams Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,276
-0.26%
|
$0
$0.98 P/Share
|
|
Aug 22
2022
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,498
-0.19%
|
$0
$0.98 P/Share
|
|
Jul 26
2022
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
5,188
-1.6%
|
$0
$0.67 P/Share
|
|
Jun 15
2022
|
David M Mott Director |
BUY
Grant, award, or other acquisition
|
Direct |
182,481
+23.33%
|
-
|
|
Jun 15
2022
|
Jan M Lundberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
91,240
+40.5%
|
-
|
|
Jun 15
2022
|
Muna Bhanji Director |
BUY
Grant, award, or other acquisition
|
Direct |
95,802
+50.0%
|
-
|
|
Jun 15
2022
|
Onaiza Cadoret Manier Director |
BUY
Grant, award, or other acquisition
|
Direct |
91,240
+48.37%
|
-
|
|
Jun 15
2022
|
Richard J Rodgers Director |
BUY
Grant, award, or other acquisition
|
Direct |
132,299
+37.57%
|
-
|
|
Jun 15
2022
|
William C Bertrand Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
118,613
+36.98%
|
-
|
|
Jun 06
2022
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
103,624
-6.73%
|
$0
$0.65 P/Share
|
|
Jun 06
2022
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
17,636
-8.24%
|
$0
$0.65 P/Share
|
|
Jun 06
2022
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
44,004
-6.34%
|
$0
$0.65 P/Share
|
|
Jun 06
2022
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
60,821
-9.7%
|
$0
$0.65 P/Share
|
|
Jun 06
2022
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
73,312
-9.26%
|
$0
$0.65 P/Share
|
|
Jun 06
2022
|
Susan Rodriguez Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
43,920
-6.6%
|
$0
$0.65 P/Share
|
|
Jun 06
2022
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
73,312
-10.99%
|
$0
$0.65 P/Share
|
|
May 20
2022
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
1,263
-0.4%
|
$0
$0.67 P/Share
|